Neuropathology in Mice Expressing Mouse Alpha-Synuclein

被引:38
|
作者
Rieker, Claus [1 ]
Dev, Kumlesh K. [2 ]
Lehnhoff, Katja [1 ]
Barbieri, Samuel [1 ]
Ksiazek, Iwona [3 ]
Kauffmann, Sabine [1 ]
Danner, Simone [1 ]
Schell, Heinrich [4 ,5 ]
Boden, Cindy [4 ,5 ]
Ruegg, Markus A. [3 ]
Kahle, Philipp J. [4 ,5 ]
van der Putten, Herman [1 ]
Shimshek, Derya R. [1 ]
机构
[1] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland
[2] Trinity Coll Dublin, Sch Med, Dept Physiol, Dublin, Ireland
[3] Univ Basel, Neurobiol Biozentrum, Basel, Switzerland
[4] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany
[5] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany
来源
PLOS ONE | 2011年 / 6卷 / 09期
关键词
IMMOBILIZED PH GRADIENTS; LEWY BODY DISEASE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SUBCELLULAR-LOCALIZATION; PROTEINASE K; BODIES; BRAIN; MODEL; INSOLUBILITY;
D O I
10.1371/journal.pone.0024834
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
alpha-Synuclein (alpha SN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (m alpha SN), which carries a threonine at position 53 like the A53T human mutant version that is genetically linked to PD, were never reported. To this end we generated mouse lines that express m alpha SN in central neurons at levels reaching up to six-fold compared to endogenous m alpha SN. Unlike transgenic mice expressing human wildtype or mutant forms of alpha SN, these m alpha SN transgenic mice showed pronounced ubiquitin immunopathology in spinal cord and brainstem. Isoelectric separation of m alpha SN species revealed multiple isoforms including two Ser129-phosphorylated species in the most severely affected brain regions. Neuronal Ser129-phosphorylated alpha SN occured in granular and small fibrillar aggregates and pathological staining patterns in neurites occasionally revealed a striking ladder of small alternating segments staining either for Ser129-phosphorylated alpha SN or ubiquitin but not both. Axonal degeneration in long white matter tracts of the spinal cord, with breakdown of myelin sheaths and degeneration of neuromuscular junctions with loss of integrity of the presynaptic neurofilament network in m alpha SN transgenic mice, was similar to what we have reported for mice expressing human alpha SN wildtype or mutant forms. In hippocampal neurons, the m alpha SN protein accumulated and was phosphorylated but these neurons showed no ubiquitin immunopathology. In contrast to the early-onset motor abnormalities and muscle weakness observed in mice expressing human alpha SN, m alpha SN transgenic mice displayed only end-stage phenotypic alterations that manifested alongside with neuropathology. Altogether these findings show that increased levels of wildtype m alpha SN does not induce early-onset behavior changes, but drives end-stage pathophysiological changes in murine neurons that are strikingly similar to those evoked by expression of human wildtype or mutant forms.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Behavioral characterization of transgenic mice expressing wild-type alpha-synuclein and mice lacking alpha-synuclein
    Fleming, SM
    Levine, MS
    Masliah, E
    Chesslet, MF
    MOVEMENT DISORDERS, 2003, 18 (09) : 1090 - 1090
  • [2] Neuropathology in mice expressing human α-synuclein
    van der Putten, H
    Wiederhold, KH
    Probst, A
    Barbieri, S
    Mistl, C
    Danner, S
    Kauffmann, S
    Hofele, K
    Spooren, WPJM
    Ruegg, MA
    Lin, S
    Caroni, P
    Sommer, B
    Tolnay, M
    Bilbe, G
    JOURNAL OF NEUROSCIENCE, 2000, 20 (16): : 6021 - 6029
  • [3] Neuropathology of conditional alpha-synuclein transgenic mouse models of Parkinson's disease
    Nuber, S.
    Petrasch-Parwez, E.
    Winner, B.
    Winkler, J.
    von Hoersten, S.
    Teismann, P.
    Schulz, J. B.
    Neumann, M.
    Fendt, M.
    Gellerich, F. N.
    Riess, O.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S122 - S122
  • [4] Neuropathology of conditional alpha-synuclein transgenic mouse models of Parkinson's disease
    Nuber, S.
    Petrasch-Parwez, E.
    Winner, B.
    Winkler, J.
    von Hoersten, S.
    Teismann, P.
    Schulz, J. B.
    Neumann, M.
    Fendt, M.
    Gellerich, F. N.
    Riess, O.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S90 - S90
  • [5] Alpha-synuclein and transgenic mouse models
    Fernagut, PO
    Chesselet, MF
    NEUROBIOLOGY OF DISEASE, 2004, 17 (02) : 123 - 130
  • [6] Neurodegeneration in alpha-synuclein transgenic mice is associated with accumulation of truncated alpha-synuclein polypeptides
    Lee, M
    Stirling, W
    Xu, YQ
    Price, D
    Copeland, N
    Jenkins, N
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S137 - S137
  • [7] Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein
    Bernis, Maria E.
    Babila, Julius T.
    Breid, Sara
    Wuesten, Katharina Annick
    Wuellner, Ullrich
    Tamgueney, Gueltekin
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2015, 3 : 75
  • [8] Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein
    Maria E. Bernis
    Julius T. Babila
    Sara Breid
    Katharina Annick Wüsten
    Ullrich Wüllner
    Gültekin Tamgüney
    Acta Neuropathologica Communications, 3
  • [9] Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein
    Tweedy, Clare
    Kindred, Nathan
    Curry, Joshua
    Williams, Christopher
    Taylor, John-Paul
    Atkinson, Peter
    Randall, Fiona
    Erskine, Daniel
    Morris, Christopheer M.
    Reeve, Amy K.
    Clowry, Gavin J.
    LeBeau, Fiona E. N.
    NEUROBIOLOGY OF DISEASE, 2021, 149
  • [10] Enhanced alpha-synuclein pathology and exacerbated motor dysfunction in alpha-synuclein transgenic mice with autophagy deficiency
    Noda, Sachiko
    Sato, Shigeto
    Yamakado, Hodaka
    Takahashi, Ryosuke
    Hattori, Nobutaka
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 758